Home›Stocks›GENI

GENI — structural market context

Genius Sports Limited

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

What changed

As of the close on Oct 23. Each line shows the earlier value, the later value and their dates.

Price

Close $6.33 (Oct 23) vs $6.54 (Oct 22): −3.21%.

Volume

0.56× its 20-session average (7.2M) on Oct 23.

Includes pre- and post-market trading.

Short interest

Short interest 38.0M shares (settlement Sep 30) vs 38.1M (Sep 15).

No new publication in this window. Latest: settlement Sep 30, published Oct 10.

Fails-to-deliver

Latest file (settlements Sep 15–Sep 30, published Oct 16): 1 day with fails, largest 6K shares on Sep 29.

Previous file (settlements Sep 1–Sep 14, published Sep 30): 4 days with fails, largest 53K shares on Sep 1.

No new publication in this window.

Analyst rating actions

None recorded in this window.

Insider filings (Form 4)

None recorded in this window.

GENI events and their magnitude

Latest SEC filing in the event study

Form 4 · other · filed 2026-10-05 · View on sec.gov ↗

…

Open the Event Study →

GENI short interest & days to cover

SHARES SHORT
38.0M
% OF FLOAT
15.6%
DAYS TO COVER
4.0
CHANGE VS PRIOR
-0.4%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-09-30 (24d ago)

GENI fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-09-29 · 25d6K$6.15
2026-09-11 · 43d3K$6.72
2026-09-10 · 44d4K$7.03

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

GENI insider buying and selling (Form 4)

Last 12 months, Form 4 codes P and S: 0 purchases · 4 sales · 1 filing not counted

InsiderTypeSharesValueFiled
Russell Thomas · officer: Chief Legal OfficerSale (S)50K$326K2026-09-18
Locke Mark · director, officer: Chief Executive OfficerSale (S)273K$1.8M2026-09-17
Locke Mark · director, officer: Chief Executive OfficerSale (S)50K$327K2026-09-17
Locke Mark · director, officer: Chief Executive OfficerPurchase (P)1—*2026-09-17
Locke Mark · director, officer: Chief Executive OfficerSale (S)1—*2026-09-17

*Value not shown: the filed price could not be checked against the U.S. listing.

SEC Form 4 filings: purchases and sales reported on Form 4 (transaction codes P and S) only; grants and option exercises excluded. Attributed public records.

GENI analyst ratings

FirmActionRatingPublished
CitigroupholdMarket Outperform2026-10-08
CitigroupholdMarket Outperform2026-09-08
BenchmarkholdBuy2026-08-28

Rating actions as published by the firms, from public feeds. They are not graded here.

Frequently asked questions

What is GENI's short interest?
As of the FINRA settlement date 2026-09-30, GENI had 38.0M shares sold short — 15.6% of its float, with 4.0 days to cover at average volume. FINRA publishes this data roughly two weeks after each twice-monthly settlement, so it is inherently delayed. A short-interest figure describes an aggregate position; it does not predict what the stock will do.
Are insiders buying GENI?
In the last 12 months of SEC Form 4 filings, GENI recorded 0 insider purchases and 4 sales reported on Form 4 (transaction codes P and S; grants and option exercises excluded). 1 filing not counted: the filed price could not be checked against the U.S. listing. These are attributed public records — information, not instruction.
What do analysts say about GENI?
The most recent action: Citigroup hold to Market Outperform on 2026-10-08. Rating actions are shown as published by the firms; they are not graded here.
Is this page telling me to buy or sell GENI?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

More tickers starting with G

GABC · German American Bancorp, Inc.GAP · The Gap, Inc.GBNXF · Gibson Energy, Inc. Common ShaGE · GE AerospaceGEF · Greif, Inc.GFS · GlobalFoundries Inc.All G →

GENI: the full history

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.